| Cannabis – Inpatient Management of patients admitted to SESLHD facilities using medicinal cannabis products
|
SESLHDPR/620 |
|
| Dispensing of Medications for Patient Take-Home Use using Paper Prescription generated by eMEDs (Prescription Output Version 2)
|
SESLHDPR/743 |
|
| Expression and Safe Management of Expressed Breast Milk
|
SESLHDGL/081 |
|
| Guideline for Use of Complementary and Alternative Medicines in Hospital Inpatients
|
SESLHDGL/021 |
|
| High-Risk Medicines Management
|
SESLHDPR/734 |
|
Management of Acute Viral Respiratory Illness (including influenza and COVID-19)
|
SESLHDPR/581 |
|
| Management of Complex Discharges / Escalation Guidelines
|
SESLHDGL/053 |
|
| Management of Deteriorating PAEDIATRIC Inpatient
|
SESLHDPR/284 |
|
| Management of missed consecutive doses of Opioid Agonist Treatment in Inpatient and Outpatient settings
|
SESLHDPR/411 |
|
| Management of Patients Suspected of Concealing Drugs Internally transferred to St George and Prince of Wales Hospital by the Australian Federal Police Force from Customs
|
SESLHDPR/361 |
|
| Management of the Deteriorating ADULT inpatient (excluding maternity)
|
SESLHDPR/697 |
|
| Management of the deteriorating MATERNITY woman
|
SESLHDPR/705 |
|
| Management of the Deteriorating NEONATAL Inpatient
|
SESLHDPR/340 |
|
| Managing Chart Access Audits in Electronic Health Records
|
SESLHDPR/522 |
|
| Managing Secure Organisation Access Within Cerner eMR
|
SESLHDPR/510 |
|
| Mass Swabbing of Cruise Ship Passengers on Disembarkation
|
SESLHDGL/113 |
|
| Master of Nursing (Nurse Practitioner) Students - Guideline for Managers
|
SESLHDGL/108 |
|
| Mastitis (Lactational) Treatment
|
SESLHDPR/352 |
|
| Maternity Services Clinical Escalation Policy
|
SESLHDPD/273 |
|
| Maternity – identifying, reviewing and reporting trigger and critical clinical events
|
SESLHDGL/095 |
|
| Maternity-Clinical Advice Provision and Completion of Telephone Enquiry Record
|
SESLHDPR/295 |
|
| Media and Communications Protocols
|
SESLHDPR/593 |
|
| Medical Practitioners - Medicare Provider Numbers
|
SESLHDPR/224 |
|
| Medicare Ineligible Patients – General Fees
|
SESLHDPR/425 |
|
| Medication - Safety Alerts, Notices and Information
|
SESLHDPR/724 |
|
| Medication Charts: Charting of Oral Nutrition Support
|
SESLHDPR/317 |
|
| Medication: Administration by Enrolled Nurses
|
SESLHDPD/160 |
|
| Medicine Recall Process
|
SESLHDPR/438 |
|
| Medicine: Continuity of Management and Documentation
|
SESLHDPR/267 |
|
| Medicine: Frusemide use in Adult Chronic Heart Failure Patients
|
SESLHDPD/169 |
|
| Medicine: Management of Refrigerated Storage of Medicines and Vaccinations in Clinical Areas
|
SESLHDPR/300 |
|
| Medicine: Managing Intraoperative Medications
|
SESLHDPR/209 |
|
| Medicine: Medicine Formulary Policy
|
SESLHDPD/183 |
|
| Medicine: Off-label use of registered medicines and use of unlicensed medicines
|
SESLHDPD/182 |
|
| Meglumine Diatrizoate and Sodium Diatrizoate (Gastrografin®) in Adult Adhesional Small Bowel Obstruction
|
SESLHDPR/570 |
|
| Methotrexate (oral)
|
|
|
| Methoxyflurane Inhaler for Acute Pain Management
|
|
|
| Mobile Phones - provisioning and use of
|
SESLHDPD/300 |
|
| Mobile Services - Procedure
|
SESLHDPR/645 |
|
| Model of Care for SESLHD Metabolic Disorders and Bariatric Surgery Service (MDBSS)
|
SESLHDGL/096 |
|
| Motor Vehicle Policy
|
SESLHDPD/285 |
|
| Pain Management - Opioid Withdrawal in Patients on Long Term Opioid Medications
|
SESLHDPR/603 |
|
| Postoperative Mobilisation
|
SESLHDGL/061 |
|
| Safe Handling and Management of Monoclonal Antibodies
|
SESLHDPR/368 |
|
| Scabies - Management of
|
SESLHDPR/363 |
|
| SESLHD Nursing and Midwifery Management of Secondary Employment
|
SESLHDBR/057 |
|
| Sterilisation: Designation of Reusable Medical Devices (RMDs) to a Product Family
|
SESLHDPR/627 |
|
| Use of Generic Medications
|
SESLHDPD/320 |
|
| Use of mesh in sacrocolpopexy and related procedures
|
SESLHDPR/747 |
|
| Work Health and Safety - Hazardous Manual Task Risk Management Procedure
|
SESLHDPR/315 |
|
